68Ga-Pentixafor PET/CT显示系统性肥大细胞增生症模拟淋巴瘤的CXCR4表达
本文报道一例64岁男性疑似血液系统恶性肿瘤患者,先后行18F-FDG和68Ga-Pentixafor PET/CT,两者均显示与骨髓受累相关的弥漫性摄取增高;68Ga-Pentixafor PET/CT还检出18F-FDG未探测到的表达CXCR4的腹腔淋巴结。患者高度怀疑淋巴瘤,但骨髓组织病理学检查证实为系统性肥大细胞增生症伴相关骨髓纤维化。
要点
- 68Ga-Pentixafor PET/CT可显示系统性肥大细胞增生症的CXCR4表达。
- 68Ga-Pentixafor检出18F-FDG未探测到的腹腔淋巴结。
- 骨髓病理证实系统性肥大细胞增生症伴骨髓纤维化。
核心结论
- 68Ga-Pentixafor PET/CT可显示系统性肥大细胞增生症中的CXCR4表达,并检出18F-FDG PET/CT未探测到的腹腔淋巴结。
研究设计与样本
- 本文为个案报道,描述一例64岁男性疑似血液系统恶性肿瘤患者行18F-FDG和68Ga-Pentixafor PET/CT检查。
主要发现
- 18F-FDG和68Ga-Pentixafor PET/CT均显示与骨髓受累相关的弥漫性摄取增高。
- 68Ga-Pentixafor PET/CT检出表达CXCR4的腹腔淋巴结,而18F-FDG PET/CT未探测到。
- 骨髓组织病理学检查证实为系统性肥大细胞增生症伴相关骨髓纤维化。
临床怎么用
- 对于疑似淋巴瘤但需鉴别系统性肥大细胞增生症的病例,68Ga-Pentixafor PET/CT可补充18F-FDG PET/CT未显示的CXCR4表达病灶信息。
局限性
- 本文为单例个案报道,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
68Ga-Pentixafor is a novel radiotracer for imaging chemokine receptor subtype 4 (CXCR4) receptors, which are expressed exceptionally high in several hematologic malignancies, including various types of lymphoma. Herein we report a case of a 64-year-old man patient with suspected hematologic malignancy who underwent 18F-FDG and 68Ga-pentixafor PET/CT. Both scans demonstrated diffusely increased activity related to bone marrow involvement. 68Ga-Pentixafor PET/CT demonstrated CXCR4-expressing intra-abdominal lymph nodes that were not detected by 18F-FDG PET/CT. The patient was highly suspicious of lymphoma; however, histopathological examination of the bone marrow revealed systemic mastocytosis with associated myelofibrosis.
引用
- Kiran MY, Apaydin Arikan E, Sanli Y, et al. CXCR4 Expression Demonstrated by 68Ga-Pentixafor PET/CT Imaging in a Case of Systemic Mastocytosis Mimicking Lymphoma. Clin Nucl Med. 2021. PMID: 34269725. doi:10.1097/RLU.0000000000003817
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。